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A rat liver plasma membrane glycoprotein, gpl IO, was compared with dipeptidyl aminopeptidase IV (DAP IV) by using Wistar rats (DAP IV- 
positive rats) and Fischer 344 rats (DAP IV-negative rats). Fischer rats also lacked gpl10 and gpl10 of Wistar rats had DAP IV activity. Further- 
more, we showed that the C-terminal sequence of gpl IO was Ser-Leu-Arg, which was the same as the C-terminal amino acid sequence deduced 
from the nucleotide sequence of the cDNA of DAP IV. According to these results, we concluded that gpl10 was identical with DAP IV. 
Dipeptidyl aminopeptidase IV; 110000 Da Glycoprotein; Fischer 344 rat; Wistar rat 
1, INTRODUCTION 
Dipeptidyl aminopeptidase IV (DAP IV: EC 
3.4.14.5) is a plasma membrane-bound peptidase which 
is widely distributed in various organs, including liver, 
where it is expressed at a high level in bile canalicular 
membranes [ 1 ,Z]. 
Many investigators have already reported that DAR 
IV may play an important role in the metabolism of 
peptides, blood clotting, extracellular matrix interac- 
tions and lymphocyte activation [3-71. On the other 
hand, membrane-bound glycoproteins are thought to 
mediate various functions of plasma membranes such 
as cell-cell interactions, transport and enzymatic activi- 
ty [8]. In particular, the 110 000 Da glycoprotein 
(gpll0) isolated from the rat liver bile canaliculi has 
been studied, mainly as to turnover and biogenesis 
pathway 19-l I]. 
In recent years, much attention has been paid to 
determining whether DAP IV and gpll0 are the same 
protein or not, but no definitive conclusion has been 
drawn yet [ 12-161. We have reported that Fischer 344 
rats (F344 rats) specifically lack DAP IV [17]. In the 
present paper, we compare Wistar rats with F344 rats, 
and confirm that gpll0 and DAP IV are identical, 
2. EXPERIMENTAL 
Gpl 10 (320 pg) was denatured for 5 min at 100°C in 0.1 M sodium 
bicarbonate (pH 8.2) and then digested with TLCK-treated Q- 
chymotrypsin (3.2 pg) in the same medium for 6 h at 37°C. The reac- 
tion was terminated by heating in boiling water for 5 min. Then the 
pH of the reaction mixture was adjusted to 5.5. The digest was ap- 
plied to an anhydrotrypsin agarose column (0.8 x 2,O cm; Takara, 
Kyoto) pre-equilibrated with 0.05 M sodium acetate (pH S.5) contain- 
ing 0.02 M CaCIZ and then the column was washed with the same buf- 
fer. The adsorbed peptides wcrc clutcd with 5 mM HCI (pH 2.5). 
Plasmu mcmbrancs wcrc prepared according IO [lg]. GpllO was 
2.3, Syrrlhesis of Ser-Lou-Arg 
Corrcspnndcrrcc ad&w S. Iwaki-Egawa, Department of Clinical Ser.LeumArg was synthesized by means of the solid phase pro. 
Uiochcmistry, Hokkaido Institute of Pharmnscutical Sciences, ccdurc, In this study, wc used ;I scmi~manual peptide synthesizer 
Kntsuraokn-cho, Otaru-shi, Hokkaido 047.02, Japan (HaMPS; Dupont/NEN l&earch Products, Boston, MA). 
purified according to [9] with some modifications. Rriefly, plasma 
membranes were solubilized for 12 h at 4°C with 10 mM Tris-HCI 
(pH 7.2) containing 0.15 M NaCI, 1 mM MgClz, 1 mM Caclz, 0.02% 
(w/v) NaN3 and 1.5Yo (v/v) Triton X-lOO(buffer A), followed by cen- 
trifugation for 20 min at 30 000 x g. The supernatant was applied to 
a ConA-Sepharose 40 column (Sigma, St. Louis, MO). The column 
was washed with buffer B (the same as buffer A. but with only 0.5% 
(v/v) Triton-X-100) and eluted with 0.2 M methyl ru-D- 
mannopyranoside in buffer B. The eluted fraction was dialyzed 
against buffer B and then applied to a wheat germ agglutinin (WGA)- 
agarose column (Seikagaku Kogyo, Tokyo). The retained glycopro- 
teins were then eluted with 0.2 M M-acetyl-D-glucosamine in buffer 8. 
The eluted fractions were dialyzed against 50 mM Tris-HCI (pH 8.0) 
containing 0,15 M NaCl and 0.1% (v/v) Triton X-100, and then ap- 
plied to a rabbit IgG anti-DAP IV-Sepharose 49 column equilibrated 
with the same buffer. The pure glycoprotein was eluted with 2 mM 
Tris-HCI (PI-I 8.0) at room temperature. 
The purity of the plasma membrane fraction was checked by assay- 
ing the following marker enzymes according to the methods given in 
the references: S’nucleotidase [l9,20], @-glucuronidase [21], 
NADPH-cytochrome c reductase [22] and succinate dehydrogenase 
[23]. DAP IV was assayed as described previously [l7]. Protein con- 
centrations were determined by the BCA Protein Assay (Pierce, 
Kockford, IL) 1241. 
2.2. Ajfinity chromatography of a chymotryplic digest of gpIl0 
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Table 1 
Intracellular distribution of marker enzymes, DAP IV and protein in liver of Wistar and F344 rats - 
Fractions 
Homogenate IoOOxg sup. 1000 x gppt. Plasma membrane fr. -__I 
Plasma membranea Wistar 0.050 f 0.013 0.052 + 0.018 0.173 f 0.066 0.352 t 0.229 
F344 0.046 -I 0.006 0.062 t 0.001 0.115 f 0.021 0.224 r 0.037 
Lysosomesb Wistar 3.09 +G 1.21 3.34 & 1.85 1.38 Z!Z 0.63 2.01 f 0.63 
F344 3.41 + 0.33 3.03 + 0.55 0.945 f 0.177 2.35 c 0.49 
Microsomes’ Wistar 0.046 * 0.003 0.153 -t 0.111 0.065 + 0.034 0.039 + 0.005 
F344 0.044 * 0.005 0.108 r 0.100 0.060 St 0.004 0.065 + 0.009 
MitochondriaJ Wistar 0.011 * 0.003 0.009 + 0.003 0.039 f o.iio5 0.003 t 0.001 
F344 0.014 * 0.004 0.009 * 0.003 0.036 + 0.004 0.004 + 0.002 
DAP IV= Wistar 0.038 k 0.013 0.017 * 0.012 0.197 * 0.04 2.43 + 0.76 
F344 0.002 1 0.001 0.002 + 0.002 0.003 f 0.003 0.001 t 0.001 
Protein recovery’ Wistar 100 79.7 t 13.9 2.31 f 0.56 0.130 c 0.014 
(070) F344 100 77.8 * 23.8 5.26 -t 1.92 0.145 + 0.007 
The data represent the means & SD for 4 separate experiments. One unit of enzyme activity equals 1 cmol of substrate changed per min. 
‘5 ‘-Nucleotidase, U/mg protein 
bp-Glucuronidase, mU/mg protein 
‘NADPH-cytochrome c reductase. U/mg protein 
“Succinate dehydrogenase, U/mg protein 
YJ/mg protein 
‘%, yield based on the homogenate 
3. RESULTS AND DISCUSSION 
First we purified gpll0. The liver homogenate was 
centrifuged at 1000 x g, the pellet was rehomogenized in 
a sucrose solution,. and 
tinuous sucrose density 
then fractionated by discon- 
gradient centrifugation, and 
finally the plasma membrane fraction was collected 
[la. 
As shown in Table I, the intracellular distribution 
patterns of the activities of marker enzymes and protein 
recovery were almost the same in Wistar and F344 rats, 
except for that of DAP IV activity. Also, solubilized 
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Fig. 1 (A). SDS-PAGE analysis of the fractions obtained during the purification of gpl IO. The electrophoresis was carried out on 7.5% SDS- 
polyacrylamidc gels, and subsequently stained with Coomassie brilliant blue, Lanes I and 2: total plasma membrane proteins extracted with lo/o 
Triton X-100, Luncs 3 and 4: ConA-Sepharose column flow-through fraction. Lanes 5 and 6: ConA-Sepharosc column eluted fraction. Lane 7: 
anti-DAP IV.Sepharose column eked fraction. Lanes 1, 3, 5 and 7 were sarnplcs from Wistar rats. Lanes 2, 4 find 6 were samples from F344 rats. 
(U) Activity staining of gpll0 after non SDS-PAGE (6% gel). Specific demonstration of DAP IV activity in the gel was carried out using the 
simultaneous azo-coupling method. The gel was incubated with Gly.Pro-pNA ut 37% until colouring bccanle visible and then with a coupling snlt 
(2Gj to yield 8 purple are dye. Bars (lcfi) indicate the positions of protein standards: thyroglobulin (669 kDn), ferritin (440 kDa), crtalasc (232 
kDa), lactate dchydrogenare (140 kDa), 8.gnlactosldate (1 I6 kDa), phosphorylase n (94 kDa), bovincserum albumin (68 kDa), ovalbunrin (45 kDa) 
and chymotrypainogcn (25 kDn). 
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plasma membrane proteins from the two strains showed 
similar SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) patterns, a difference being one protein band, 
which corresponded to a molecular weight of about 
110,000 (Fig. IA, lanes 1 and 2). The SDS-PAGE pat- 
terns were similar to those that we had already reported 
for the membranes of Wistar and F344 rat kidneys [17]. 
Following the purification of gpll0, the solubilized 
plasma membranes were applied to a ConA-Sepharose 
column. The 110 000 Da protein of Wistar rats was ad- 
sorbed on ConA-Sepharose (Fig. IA), lane 5), but the 
other proteins of F344 rats showed a similar pattern to 
that of Wistar rats (Fig. IA, lanes 3-6). The SDS- 
PAGE patterns of WGA-agarose-adsorbed fractions, 
after ConA-Sepharose column chromatography, were 
the same as those seen in lanes 5 and 6 of Fig. IA (data 
not shown). Though other investigators have purified 
gpll0 in a denatured form from gels after SDS-PAGE 
of a WGA-agarose adsorbed sample, we used another 
approach to get an undenatured form of gpll0. The 
WGA-agarose-adsorbed fraction was applied to a rab- 
bit IgG anti-DAP IV-Sepharose column. The effluent 
only showed the I. IO 000 Da protein band (Fig. lA, lane 
7). The purified gpl IO was run on non-SDS-PAGE. In 
the range of 200 000 - 300 000 Da, which correspond- 
ed to the molecular weight of native DAP IV [ZSJ, Gly- 
Pro-pNA was hydrolyzed (Fig. 1B). From these results, 
we deduced that F344 rats also lack gpll0 and that 
gpll0 is identical with DAP IV. 
Recently, the sequences of cDNAs for rat BAP IV 
and gpl IO were published [16,27]. The predicted amino 
acid sequences of DAP IV and gpl IO showed striking 
homology, but there were differences in 5 amino acid 
residues at corresponding positions when they were 
compared up to position 767. DAP IV has the entire se- 
quence of 767 residues, while gpl JO has 792 residues. 
The C-terminal sequences of DAP IV and gpll0 are 
shown in Fig. 2. As DAP IV and gpl IO are the same 
protein, we analyzed the C-terminal sequence of gpl10, 
which we obtained from Wistar rat liver, to resolve this 
inconsistency. 
The C-termini of DAP IV and gpll0, predicted from 
their cDNA sequences, contain an Arg residue, so we 
used an efficient method that is useful for the selective 
isolation of C-terminal peptide from a digestion mix- 
ture of a protein, taking advantage of a unique property 
of immobilized anhydrotrypsin [28]. The chymotryptic 
digest of Wistar rat liver gpll0 was applied to an 
anhydrotrypsin agarose column, Most of peptides pass- 
Fig. 2. Cotltparisoll of ~lre C-tcrminrl amino acid scquenccs of t)AP 
IV nnd gpll0. ii) rcfcrcnce (161, b) rekrencc (271. A single Icttcr code 
is used for the amifta acids. 
ed through the column. The adsorbed fraction was sub- 
jected to reversed-phase high-performance liquid 
chromatography (HPLC). The HPLC pattern of the 
fraction is shown in Fig. 3A. The adsorbed fraction 
gave a few peaks, but there was only one peak which 
contained a peptide that could be determined by means 
of the fluorescamine reaction (indicated by a shaded 
bar). The peptide in this peak was concentrated an.d its 
amino acid composition was determined with an amino 
acid analysis system (Shimadzu, Kyoto). Three amino 
acids, that is, Ser, Leu and Arg, were detected. As 
anhydrotrypsin shows strong affinity for peptides con- 
taining Arg or Lys residues at their C-termini, the C- 
terminal sequence of gpll0 is thought o be (Ser, Leu)- 
Arg. We then synthesized a peptide, Ser-Leu-Arg, using 
a semi-manual peptide synthesizer, and subjected to 
reversed-phase HPLC (Fig. 3B). The synthetic Ser-Leu- 
Arg showed the same retention time as that of the pep- 
tide peak. From this, the C-terminal sequence of gpl10 
was found to be Ser-Lea-&g, which is the same se- 
quence as the predicted sequences from the cDNA of 
DAP IV [16]. The inconsistency of the C-terminal se- 
quence of DAP IV and gpll0 might be caused by a 
frame shift of reading nucleotides. 
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Fig. 3. Reversed-phase HPLC of the chymotryptic egtidcs recovered 
in the wlsorbed frtlction on anhydrotrypsin agarose chromatography 
(A) WI the synthetic Ser-Lcu-Arg (B). (A) Chytnotryptic pcptides 
prcparcd tts dcscribcd in sectiotl 2 were subjected to reversed-phuse 
WPLC on a columr, of 7X-gel ODS-120 (0.46 x 25 cm). Elutton was 
porrormcd with G% acctonitriic in 0.1% trlfluoroacetic acid at n flow 
rate of 0.5 ml/mitt and rhc 215 nm absorbance was tncasurcd. Frac- 
tions of O,S ml were colkctcd, The peptidc cotxentratiutl of each frac- 
tion was measured by fluoromctry with fluarencttmine (shaded bar). 
(8) 2 mnl synthetic Ser.Ccu-Arg. 
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